Targeting the ANGPT–TIE2 pathway in malignancy

Hanhua Huang, Abhijit Bhat(Pfizer (United States)), Gary Woodnutt(Pfizer (United States)), Rodney W. Lappe(Pfizer (United States))

Nature reviews. Cancer

July 23, 2010

10.1038/nrc2894

Cited by 474

Abstract

Related Papers

Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning

Samuel Davis, Thomas H. Aldrich, Pamela F. Jones et al.|Cell|1996|2k

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

John M.L. Ebos, Christina R. Lee, William Cruz‐Muñoz et al.|Cancer Cell|2009|1.7k

Angiopoietin-1 protects the adult vasculature against plasma leakage

Gavin Thurston, John S. Rudge, Ella Ioffe et al.|Nature Medicine|2000|1.3k

Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell–cell and cell–matrix contacts

Pipsa Saharinen, Lauri Eklund, Juho J. Miettinen et al.|Nature Cell Biology|2008|455

Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium

Hai Tao Yuan, Eliyahu V. Khankin, S. Ananth Karumanchi et al.|Molecular and Cellular Biology|2009|373